ClinicalTrials.gov
public full text
Public Domain
Benefits of Hemodialysis With Citrate (ABC-treat) Study
Prospective randomized cross-over multicenter study to demonstrate the benefits of hemodialysis without acetate dialysate, with citrate. 32 weeks duration, in two phases. In the first, half of the patients started with citrate dialysate for 16 weeks and the other half with acetate dialysate, and then patients cross. The primary objective is to analyze the effect of citrate dialysate on acid base balance decreasing chronic metabolic acidosis and avoiding / reducing post-dialytic alkalosis.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- The Influences of Dialysate Bicarbonate Concentrations on Hemodialysis Patients#1088992
- Transition to Ferric Citrate Among Hemodialysis and Peritoneal Dialysis Patients#909365
- The Effect of Citrate Dialysate on Clot Formation and Anemia in Hemodialysis Patients#272440
- Incremental Haemodialysis in Incident Patients#849931
- Prevalence and Predictors of Nonadherence to Treatment in Adult Patients Undergoing In-Centre Haemodialysis in Public Dialysis Units: A Quantitative Cross-Sectional Study.#1091544
Record · ID 981114
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive